Influences of obesity on the immunogenicity of Hepatitis B vaccine

References

• Qiu Y, Ren J, Yao J. Healthy adult vaccination: An urgent need to prevent hepatitis B in China. Hum Vaccin Immunother 2016; 12:773-8; PMID:26337328; http://dx.doi.org/10.1080/21645515.2015.1086519
   PubMed Web of Science ®Google Scholar
• Vitaliti G, Praticò AD, Cimino C, Di Dio G, Lionetti E, La Rosa M, Leonardi S. Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow. World J Gastroenterol 2013; 19:838-845; PMID:23430309; http://dx.doi.org/10.3748/wjg.v19.i6.838
   PubMed Web of Science ®Google Scholar
• Anderson CL, Remschmidt C, Drobnitzky FP, Falkenhorst G, Zimmermann R, Wichmann O, Harder T. Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany. Hum Vaccin Immunother 2016; 12:779-784. PMID:26633195; http://dx.doi.org/10.1080/21645515.2015.1105414
   PubMed Web of Science ®Google Scholar
• Wiesen E, Diorditsa S, Li X. Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990–2014. Vaccine 2016; 34:2855-2862; PMID:27020710; http://dx.doi.org/10.1016/j.vaccine.2016.03.060
   PubMed Web of Science ®Google Scholar
• Young KM, Gray CM, Bekker LG. Is obesity a risk factor for vaccine non-responsiveness? PLoS One 2013; 8(12):e82779; PMID:24349359; http://dx.doi.org/10.1371/journal.pone.0082779
   PubMed Web of Science ®Google Scholar
• Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, Xu K, Ren J, Yao J, Li Y, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep 2016; 6:27251; PMID:27324884; http://dx.doi.org/10.1038/srep27251
   PubMed Web of Science ®Google Scholar
• Tagliabue C, Principi N, Giavoli C, Esposito S. Obesity: impact of infections and response to vaccines. Eur J Clin Microbiol Infect Dis 2016; 35:325-31; PMID:26718941; http://dx.doi.org/10.1007/s10096-015-2558-8
   PubMed Web of Science ®Google Scholar
• Andersen CJ, Murphy KE, Fernandez ML. Impact of Obesity and metabolic syndrome on immunity. Adv Nutr 2016; 7:66-75; PMID:26773015; http://dx.doi.org/10.3945/an.115.010207
   PubMed Web of Science ®Google Scholar
• Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med (Maywood) 2010; 235:1412-1424; PMID:21127339; http://dx.doi.org/10.1258/ebm.2010.010227
   PubMed Web of Science ®Google Scholar
• Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine 2015; 33:4422-4429; PMID:26163925; http://dx.doi.org/10.1016/j.vaccine.2015.06.101
   PubMed Web of Science ®Google Scholar
• Letvin NL. Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity 2007; 27:366-369; PMID:17892845
   PubMed Web of Science ®Google Scholar
• Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, Nalca A, Hooper JW, Whitehouse CA, Schmitz JE, et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med 2005; 11:740-747; PMID:15951823
   PubMed Web of Science ®Google Scholar
• Miyake T, Akbar SM, Yoshida O, Chen S, Hiasa Y, Matsuura B, Abe M, Onji M. Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease. J Gastroenterol 2010; 45:859-867; PMID:20195647; http://dx.doi.org/10.1007/s00535-010-0218-4
   PubMed Web of Science ®Google Scholar
• Park HL, Shim SH, Lee EY, Cho W, Park S, Jeon HJ, Ahn SY, Kim H, Nam JH. Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine. Hum Vaccin Immunother 2014; 10:1181-6; PMID:24614530; http://dx.doi.org/10.4161/hv.28332
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, Mendez NV, Landin AM, Ryan JG, Blomberg BB. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013; 3:3603-10; PMID:23711934; http://dx.doi.org/10.1016/j.vaccine.2013.05.003
   PubMed Web of Science ®Google Scholar
• Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol 2006; 176:7745-7752; PMID:16751422
   PubMed Web of Science ®Google Scholar
• Najarro K, Nguyen H, Chen G, Xu M, Alcorta S, Yao X, Zukley L, Metter EJ, Truong T, Lin Y, et al. Telomere length as an indicator of the robustness of B- and T-Cell response to influenza in older adults. J Infect Dis 2015; 212:1261-1269; PMID:25828247; http://dx.doi.org/10.1093/infdis/jiv202
   PubMed Web of Science ®Google Scholar
• Njajou OT, Cawthon RM, Blackburn EH, Harris TB, Li R, Sanders JL, Newman AB, Nalls M, Cummings SR, Hsueh WC. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond) 2012; 36:1176-1179; PMID:22005719; http://dx.doi.org/10.1038/ijo.2011.196
   PubMed Web of Science ®Google Scholar
• Duong MT, Sahin E. RAP1: protector of telomeres, defender against obesity. Cell Rep 2013; 3:1757-1758; PMID:23809762; http://dx.doi.org/10.1016/j.celrep.2013.06.011
   PubMed Web of Science ®Google Scholar
• Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985; 254:3187-3189; PMID:2933532
   PubMed Web of Science ®Google Scholar
• Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. N Engl J Med 1986; 314:1393; PMID:2939347
   PubMed Web of Science ®Google Scholar
• Bandaru P, Rajkumar H, Nappanveettil G. Altered or impaired immune response upon vaccination in WNIN/Ob rats. Vaccine 2011; 29:3038-3042; PMID:21320543; http://dx.doi.org/10.1016/j.vaccine.2011.01.107
   PubMed Web of Science ®Google Scholar
• Janssen JM, Jackson S, Heyward WL, Janssen RS. Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18–70 years of age. Vaccine 2015; 33:3614-3618; PMID:26067185; http://dx.doi.org/10.1016/j.vaccine.2015.05.070
   PubMed Web of Science ®Google Scholar
• Estévez ZC, Betancourt AA, Muzio González V, Baile NF, Silva CV, Bernal FH, Arias EP, Delhanty Fernández A, Olazábal NM, del Río Martín A, et al. Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults. Biologicals 2007; 35:115-122; PMID:17056272
   PubMed Web of Science ®Google Scholar
• Dinelli MI, Moraes-Pinto MI. Seroconvertion to hepatitis B vaccine after weight reduction in obese non-responder. Rev Inst Med Trop Sao Paulo 2008; 50:129-130; PMID:18488095
   PubMed Web of Science ®Google Scholar
• Fan W, Chen X, Shen C, Guo Z, Dong C. Hepatitis B vaccine response in obesity: A meta-analysis. Vaccine 2016; 34:4835-4841; PMID:27546877; http://dx.doi.org/10.1016/j.vaccine.2016.08.027
   PubMed Web of Science ®Google Scholar
• Callahan ST, Wolff M, Hill HR, Edwards KM. NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group. Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis 2014; 210:1270-1274. http://dx.doi.org/10.1093/infdis/jiu245. PMID:24795475
   PubMed Web of Science ®Google Scholar
• Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR. Hepatitis B vaccination. Hum Vaccin Immunother 2015; 11:53-57. PMID:25483515; http://dx.doi.org/10.4161/hv.34306
   PubMed Web of Science ®Google Scholar
• Sticchi L, Caligiuri P, Cacciani R, Alicino C, Bruzzone B. Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants. Hum Vaccin Immunother 2013; 9:568-571; PMID:23296324
   PubMed Web of Science ®Google Scholar
• Schillie SF, Xing J, Murphy TV, Hu DJ. Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999–2010. J Viral Hepat 2012; 19:674-676; PMID:22863272; http://dx.doi.org/10.1111/j.1365-2893.2012.01616.x
   PubMed Web of Science ®Google Scholar
• Tavakolpour S, Sali S, Gachkar L. Association of plasma levels of vitamin D with chronic hepatitis B infection. Hepat Mon 2016; 16:e35525; PMID:27110263; http://dx.doi.org/10.5812/hepatmon.35525
   PubMed Web of Science ®Google Scholar
• Zhu H, Wang Y, Yu L, Xu Y, Zhou H, Ding Y, Wang A, Liu X, Dong C. Serological and molecular analysis on the relationships between type 2 diabetes mellitus and hepatitis B virus infection. J Infect Dev Ctries 2016; 10:837-844; PMID:27580329; http://dx.doi.org/10.3855/jidc.7656
   PubMed Web of Science ®Google Scholar
• Zhu H, Liu X, Ding Y, Zhou H, Wang Y, Zhou Z, Li X, Zhang Z, Dong C. Relationships between low serum vitamin D levels and HBV “a” determinant mutations in chronic hepatitis B patients. J Infect Dev Ctries 2016; 10:1025-1030; PMID:27694737; http://dx.doi.org/10.3855/jidc.7459
   PubMed Web of Science ®Google Scholar